Breast cancer: from guidelines to personalized oncology

Por Conte PierFranco, Guarneri Valentina
Publicado em 2013-06-01

Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities

Por Dieci, Maria Vittoria, Orvieto, Enrico, Dominici, Massimo, Conte, PierFranco, Guarneri, Valentina
Publicado em 2014

Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report

Por Malavasi, Norma, Ponti, Giovanni, Depenni, Roberta, Bertolini, Federica, Zironi, Sandra, Luppi, Gabriele, Conte, Pier Franco
Publicado em 2009

Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature

Por Di Liso, Elisabetta, Pennelli, Natale, Lodovichetti, Gigliola, Ghiotto, Cristina, Dei Tos, Angelo Paolo, Conte, PierFranco, Bonanno, Laura
Publicado no Cancer Biol Ther (2015)

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature

Por Polo, Valentina, Zago, Giulia, Frega, Stefano, Canova, Fabio, Bonanno, Laura, Favaretto, Adolfo, Bonaldi, Laura, Bertorelle, Roberta, Conte, PierFranco, Pasello, Giulia
Publicado no Am J Case Rep (2015)

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

Por Danesi, Romano, Innocenti, Federico, Fogli, Stefano, Gennari, Alessandra, Baldini, Editta, Di Paolo, Antonello, Salvadori, Barbara, Bocci, Guido, Conte, Pier Franco, Del Tacca, Mario
Publicado em 2002

Bevacizumab Treatment for Advanced Breast Cancer

Por Alvarez, Ricardo H., Guarneri, Valentina, Icli, Fikri, Johnston, Stephen, Khayat, David, Loibl, Sibylle, Martin, Miguel, Zielinski, Christoph, Conte, PierFranco, Hortobagyi, Gabriel N.
Publicado em 2011

Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation

Por Dominici, Massimo, Rasini, Valeria, Bussolari, Rita, Chen, Xiaohua, Hofmann, Ted J., Spano, Carlotta, Bernabei, Daniela, Veronesi, Elena, Bertoni, Filippo, Paolucci, Paolo, Conte, PierFranco, Horwitz, Edwin M.
Publicado em 2009

A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer

Por Rugo, Hope S., Campone, Mario, Amadori, Dino, Aldrighetti, Daniela, Conte, PierFranco, Wardley, Andrew, Villanueva, Cristian, Melisko, Michelle, McHenry, M. Brent, Liu, David, Lee, Francis, Pivot, Xavier
Publicado em 2013

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

Por Bonanno, Laura, Zago, Giulia, Marulli, Giuseppe, Del Bianco, Paola, Schiavon, Marco, Pasello, Giulia, Polo, Valentina, Canova, Fabio, Tonetto, Fabrizio, Loreggian, Lucio, Rea, Federico, Conte, PierFranco, Favaretto, Adolfo
Publicado no Onco Targets Ther (2016)

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Th...

Por Baselga, José, Gelmon, Karen A., Verma, Shailendra, Wardley, Andrew, Conte, PierFranco, Miles, David, Bianchi, Giulia, Cortes, Javier, McNally, Virginia A., Ross, Graham A., Fumoleau, Pierre, Gianni, Luca
Publicado no J Clin Oncol (2010)

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

Por Pasello, Giulia, Urso, Loredana, Mencoboni, Manlio, Grosso, Federica, Ceresoli, Giovanni Luca, Lunardi, Francesca, Vuljan, Stefania Edith, Bertorelle, Roberta, Sacchetto, Valeria, Ciminale, Vincenzo, Rea, Federico, Favaretto, Adolfo, Conte, PierFranco, Calabrese, Fiorella
Publicado no Oncotarget (2015)

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for...

Por Guarneri, Valentina, Dieci, Maria Vittoria, Frassoldati, Antonio, Maiorana, Antonino, Ficarra, Guido, Bettelli, Stefania, Tagliafico, Enrico, Bicciato, Silvio, Generali, Daniele Giulio, Cagossi, Katia, Bisagni, Giancarlo, Sarti, Samanta, Musolino, Antonino, Ellis, Catherine, Crescenzo, Rocco, Conte, PierFranco
Publicado no Oncologist (2015)

Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers

Por Grisendi, Giulia, Bussolari, Rita, Veronesi, Elena, Piccinno, Serena, Burns, Jorge S, De Santis, Giorgio, Loschi, Pietro, Pignatti, Marco, Di Benedetto, Fabrizio, Ballarin, Roberto, Di Gregorio, Carmela, Guarneri, Valentina, Piccinini, Lino, Horwitz, Edwin M, Paolucci, Paolo, Conte, PierFranco, Dominici, Massimo
Publicado em 2011

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breas...

Por Catania, Chiara, Maur, Michela, Berardi, Rossana, Rocca, Andrea, Giacomo, Anna Maria Di, Spitaleri, Gianluca, Masini, Cristina, Pierantoni, Chiara, González-Iglesias, Reinerio, Zigon, Giulia, Tasciotti, Annaelisa, Giovannoni, Leonardo, Lovato, Valeria, Elia, Giuliano, Menssen, Hans D, Neri, Dario, Cascinu, Stefano, Conte, Pier Franco, de Braud, Filippo
Publicado no Cell Adh Migr (2015)